Share This Page
Drug Price Trends for NDC 31722-0568
✉ Email this page to a colleague
Average Pharmacy Cost for 31722-0568
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DARUNAVIR 600 MG TABLET | 31722-0568-60 | 1.18571 | EACH | 2025-11-19 |
| DARUNAVIR 600 MG TABLET | 31722-0568-60 | 1.17225 | EACH | 2025-10-22 |
| DARUNAVIR 600 MG TABLET | 31722-0568-60 | 1.20915 | EACH | 2025-09-17 |
| DARUNAVIR 600 MG TABLET | 31722-0568-60 | 1.19906 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 31722-0568
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 31722-0568
Introduction
As an essential step in strategic decision-making for pharmaceutical stakeholders, comprehensive market analysis and accurate price projections for specific drugs delineate business opportunities and inform pricing strategies. This report evaluates NDC 31722-0568 to provide insights into its current market landscape, competitive positioning, regulatory environment, and future price trajectory. The analysis combines pharmaceutical market trends, reimbursement factors, generic competition, and evolving regulatory policies to generate a reliable forecast.
Product Overview and Regulatory Status
NDC 31722-0568 corresponds to (insert specific drug name, e.g., "Drug X, 100 mg"). Manufactured by (manufacturer name), it has gained approval from the FDA, primarily indicated for (specific indication, e.g., "treatment of chronic migraine"). Its recent market entry situates it among emergent therapeutics, with patent exclusivity likely extending until (approximate patent expiry date).
Given the evolving landscape, the drug's regulatory environment includes considerations such as:
- Patent protections and exclusivity periods
- FDA approval and label scope
- Potential for biosimilar or generic entries following patent expiration
These factors significantly influence the market dynamics and pricing potential.
Market Landscape Analysis
Market Size and Growth Trends
According to recent industry reports [1], the global market for (therapeutic class) reached approximately $X billion in 2022, with a compounded annual growth rate (CAGR) of Y% projected through 2030. The US represents a critical segment, accounting for nearly Z% of the total market, driven by factors such as high disease prevalence, innovative treatment protocols, and reimbursement frameworks.
Specifically, the (indication area) segment demonstrates promising expansion:
- Prevalence data shows approximately X million patients in North America alone.
- Rising awareness and improved diagnostics are expanding treatment candidates.
- Patient access initiatives potentially increase utilization.
Competitive Landscape
NDC 31722-0568 faces competition from:
- Market-leading branded therapeutics currently capturing A% of the market.
- Emerging generics and biosimilars poised to challenge pricing post patent expiry.
- Alternative modalities, such as biosimilar entries or combination therapies, potentially impacting market share.
Key competitors include (competitor drugs, e.g., "Drug Y," "Drug Z"), with established prescriber bases and entrenched reimbursement policies.
Reimbursement Dynamics
Reimbursement considerations heavily influence market penetration and pricing strategies:
- Medicare and Medicaid reimbursement rates typically favor lower-cost generics.
- Commercial payers increasingly incentivize biosimilars to contain costs.
- Manufacturer-payer negotiations and formulary placements can significantly modify effective market prices.
Pricing Environment and Developmental Trends
Current Price Points
The average wholesale price (AWP) for NDC 31722-0568 is approximately $X per unit/dose, aligning with comparable products in its class. Its list price positions it within the (premium/competitive) segment, contingent on therapeutic efficacy, safety profile, and market positioning.
Factors Affecting Price Trajectory
- Patent and exclusivity status: As patent protection approaches expiration, generic competition is likely to exert downward pressure, potentially resulting in a 20-40% price reduction.
- Regulatory approvals: Additional indications could expand the market size, supporting maintained or increased pricing.
- Market penetration and reimbursement policies: Favorable coverage agreements can sustain higher prices; conversely, payer pressure may precipitate discounts.
- Manufacturer strategies: Launch of value-added features or differentiated formulations can justify premium pricing.
Price Projection Scenarios
| Scenario | Timeline | Assumptions | Price Trajectory | Implication |
|---|---|---|---|---|
| Optimistic (High Revenue) | 3-5 years | Patent extension, expanded indications, favorable reimbursement | Stable or slight increase; up to $X | Continued premium pricing sustains revenue growth |
| Base Case | 3-5 years | Patent expiry, gradual entry of generics, moderate competition | 25-50% decrease post patent expiry; stabilizes around $Y | Market share shifts but revenue remains viable with differentiation strategies |
| Pessimistic (Competitive Threat) | 2-4 years | Rapid generic entry, aggressive pricing, biosimilar competition | 60-80% reduction; prices fall to $Z | Revenue pressures necessitate cost restructuring or labeling adjustments |
Note: Precise figures are contingent upon market developments and actual competitive responses.
Strategic Considerations for Stakeholders
- Patent Litigation and Exclusivity Management: Protecting patent rights can defer generic entry and preserve higher pricing.
- Market Expansion: Broadening indications enhances market size, supporting price sustainability.
- Pricing and Contracting Strategies: Engaging payers early to secure favorable formulary positions mitigates downward price pressures.
- Lifecycle Planning: Preparing for patent cliff by innovating formulations or securing brand differentiation prolongs profitability.
Key Takeaways
- The current market for NDC 31722-0568 is characterized by a niche that may expand with additional indications and preferential payer arrangements.
- The product's pricing strategy should align with patent protections, competitive dynamics, and reimbursement frameworks.
- Post-patent expiration, generic and biosimilar competition is projected to induce significant price reductions, emphasizing the importance of lifecycle management.
- The evolving regulatory and market landscape necessitates agile pricing approaches, including value demonstration and strategic contracting.
- To optimize market position and price realization, stakeholders should consider early lifecycle planning, patent strategies, and payer engagement.
Frequently Asked Questions
1. What are the key factors influencing the price of NDC 31722-0568?
Price determinants include patent status, competitive landscape, reimbursement policies, clinical efficacy, and manufacturing costs. Patent protection and formulary positioning primarily drive initial pricing, whereas competition and generic entry exert downward pressure over time.
2. How does patent expiration impact the drug’s pricing?
Patent expiration typically leads to market entry of generics and biosimilars, resulting in substantial price reductions—often between 20% and 80%—to accommodate the increased competition.
3. What is the potential market size for NDC 31722-0568?
Market size depends on the target indication, prevalence, and geographic coverage. In the US, for an established indication, the market can range from hundreds of thousands to several million patients, with potential growth through label expansion.
4. How do reimbursement policies affect the drug’s marketability?
Reimbursement policies determine affordability and access, influencing prescriber and patient uptake. Favorable payer coverage and formulary placement support higher prices, while high out-of-pocket costs can restrain utilization.
5. What strategies can manufacturers employ to sustain pricing amidst competition?
Manufacturers may pursue differentiation through clinical benefits, expand indications, implement patient assistance programs, or engage in strategic pricing negotiations with payers to maintain market competitiveness.
Conclusion
NDC 31722-0568 operates within a dynamic and competitive pharmaceutical landscape. Its current pricing landscape is shaped by patent protections, market penetration strategies, and reimbursement environments. Future price trajectories hinge on patent duration, competitive entry, and expansion of therapeutic indications. Strategic lifecycle management and proactive payer engagement remain pivotal for maximizing commercial value.
References
[1] IQVIA. (2022). The Global Use of Medicine.
[2] U.S. Food and Drug Administration. (2022). Drug Approvals and Labeling.
[3] EvaluatePharma. (2022). World Preview - Oncology/Biopharmaceuticals.
[4] SSR Health. (2022). Market Access and Pricing Data.
[5] Centers for Medicare & Medicaid Services. (2022). Drug Reimbursement Policies.
Note: Details such as specific drug name, manufacturer, and indications should be inserted once verified.
More… ↓
